Clinical Trial

The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study aims to confirm that SHR20004 is more effective than placebo in controlling blood glucose in patients with type 2 diabetes. Evaluate the efficacy, safety, and pharmacokinetics of SHR20004 after 24 weeks of treatment.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-10-17; most recent amendment 2025-07-31.
Status change: Recruiting → Active, Not Recruiting 2025-07-31
Status change: Not Yet Recruiting → Recruiting 2024-11-13
Trial Details
NCT Number NCT06649773
Lead Sponsor Jiangsu HengRui Medicine Co., Ltd.
Conditions Type 2 Diabetes
Enrollment 137 participants
Start Date 2024-10-25
Primary Completion 2025-05-28 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-05